reviewTop 10% cited
Etoposide: four decades of development of a topoisomerase II inhibitor
European Journal of Cancer · 1998 · Vol. 34(10) · pp. 1514–1521
Kenneth R. Hande✉(Vanderbilt University)
Cancer therapeutics and mechanismsLung Cancer Research StudiesPlant-derived Lignans Synthesis and BioactivityEtoposidePodophyllotoxinTopoisomerasePharmacologyTeniposideProdrugTopoisomerase inhibitorChemistryMedicineCancer research
MeSH terms
Administration, OralAntineoplastic Agents, PhytogenicEtoposideHumansMitoxantroneNeoplasmsTechnology, PharmaceuticalTeniposideAnthracyclinesTopoisomerase II Inhibitors
Citations
934
FWCI
3.12
field-weighted impact
References
83
Percentile
92%
vs. same field & year
Citations per year
Cited by
Mechanisms and Consequences of Double‐Strand DNA Break Formation in Chromatin
Journal of Cellular Physiology · 2015 · 472 citations
Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids
European Journal of Medicinal Chemistry · 2014 · 426 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.